Artisan Plastic Surgery and Artisan Beauté have been acquired by Olympus Cosmetic Group
Olympus Cosmetic Group, a platform providing comprehensive cosmetic surgery, dermatological treatments and non-surgical cosmetic procedures, has completed the acquisition of Artisan Plastic Surgery, LLC and Artisan Beauté, LLC (collectively Artisan), a female-founded and managed cosmetic surgery and medspa enterprise.
Artisan is a premier US cosmetic and reconstructive plastic surgery practice and luxury medspa business serving patients in the metro Atlanta region and beyond since 2000. Headquartered in Atlanta, Artisan operates four locations that provide leading-edge treatments to patients. Supported by a talented team of female surgeons, its highly complementary Artisan Beauté medspa locations provide patients with access to Artisan’s comprehensive and skillfully performed non-surgical aesthetic procedures.
Olympus is a provider of comprehensive cosmetic surgery, dermatological treatments and non-surgical cosmetic procedures located in Southeast USA. It is a portfolio company of VSS Capital Partners, which was founded in 1987 and is headquartered in New York. VSS is a private investment firm that invests in lower middle-market healthcare, business services and education companies.
Oaklins TM Capital in the USA served as the exclusive financial advisor to Artisan Plastic Surgery and Artisan Beauté in its sale to Olympus Cosmetic Group.
Dr. Diane Alexander
Founder, Artisan Plastic Surgery
Contáctese con el equipo de la transacción
Michael S. Goldman
Oaklins TM Capital
Transacciones relacionadas
MEDIK Hospital Design Group has been acquired by STERIS
The private shareholders of MEDIK Hospital Design Group have sold their shares to STERIS plc. Together, MEDIK and STERIS will expand their offerings for hospitals and ambulatory surgery centers worldwide. MEDIK’s solutions ideally complement STERIS’ existing portfolio, enabling the combined group to strengthen its position as a leading provider of turnkey room solutions in surgical and IPT environments. The MEDIK management team will actively support the next phase of growth.
Aprenda másbioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG
Rancoderm GmbH has been acquired by Rose Investment- und Beteiligungs AG to secure the funding required for the final development and market approval of its medical device DermaPro. The acquisition will enable Rancoderm to bring DermaPro to market readiness and launch it as a certified medical product for broad distribution.
Aprenda másBanook, backed by Motion Equity, has acquired Fluidda
Banook Group has acquired Fluidda NV, marking a strategic expansion into advanced in-silico trials and respiratory disease modeling. Combining Banook’s expertise in cardiac safety and clinical data services with Fluidda’s AI-driven respiratory analytics creates a powerful, integrated platform. This deal strengthens Banook’s position in the contract research organization (CRO) sector, offering pharmaceutical clients broader, technology-enabled solutions to drive drug development and reduce costs.
Aprenda más